DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+1.33%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.76B
AUM Growth
-$301M
(-6%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-20.02%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
169
New
40
Increased
23
Reduced
18
Closed
45
Top Buys
| 1 |
Edgewise Therapeutics
EWTX
|
$128M |
| 2 |
Boston Scientific
BSX
|
$110M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$88.6M |
| 4 |
Neurocrine Biosciences
NBIX
|
$70.5M |
| 5 |
Organogenesis Holdings
ORGO
|
$54.6M |
Top Sells
| 1 |
Nkarta
NKTX
|
$87.3M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$65.1M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
$58.2M |
| 4 |
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
|
$56.1M |
| 5 |
DFHTU
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
|
$50.4M |
Sector Composition
| 1 | Healthcare | 70.89% |
| 2 | Consumer Discretionary | 0.23% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCR
26
DELISTED
Oncorus, Inc.
ONCR
| $43.8M | 0.92% |
3,148,977
+300,000
| +11% | +$4.18M |
|
27
Pulmonx
LUNG
$70.9M
| $42.9M | 0.9% |
937,032
+473,521
| +102% | +$21.7M |
|
28
Rhythm Pharmaceuticals
RYTM
$6.78B
| $42.3M | 0.89% |
1,989,625
-731,578
| -27% | -$15.6M |
|
|
RETA
29
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $41.9M | 0.88% |
420,000
+100,000
| +31% | +$9.97M |
|
|
SWTX
30
DELISTED
SpringWorks Therapeutics
SWTX
| $41.1M | 0.86% |
558,574
-884,396
| -61% | -$65.1M |
|
|
CNST
31
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $40M | 0.84% |
1,708,957
+250,000
| +17% | +$5.85M |
|
|
INZY
32
DELISTED
Inozyme Pharma
INZY
| $38.9M | 0.82% |
1,964,000
+813,701
| +71% | +$16.1M |
|
|
BDSI
33
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $37.3M | 0.78% |
9,530,000
| – | – |
|
34
Puma Biotechnology
PBYI
$253M
| $36.6M | 0.77% |
3,769,795
-189,946
| -5% | -$1.85M |
|
|
ISEE
35
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $35.6M | 0.75% |
5,767,409
| – | – |
|
|
APR
36
DELISTED
Apria, Inc. Common Stock
APR
| $33.5M | 0.7% |
+1,200,000
| New | +$33.5M |
|
37
Protagonist Therapeutics
PTGX
$3.77B
| $32.6M | 0.69% |
1,258,790
-121,181
| -9% | -$3.14M |
|
38
Nuvation Bio
NUVB
$1.33B
| $31.4M | 0.66% |
+3,000,000
| New | +$31.4M |
|
|
HRC
39
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $30.9M | 0.65% |
+279,870
| New | +$30.9M |
|
|
XLRN
40
DELISTED
Acceleron Pharma Inc.
XLRN
| $29.8M | 0.63% |
219,500
-202,119
| -48% | -$27.4M |
|
41
Xeris Biopharma Holdings
XERS
$1.27B
| $29.6M | 0.62% |
+6,553,398
| New | +$29.6M |
|
42
CalciMedica
CALC
$43M
| $29.3M | 0.62% |
377,265
| – | – |
|
43
Pharvaris
PHVS
$1.48B
| $28.9M | 0.61% |
+1,032,757
| New | +$28.9M |
|
|
ITMR
44
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $28.6M | 0.6% |
1,193,803
+400,000
| +50% | +$9.58M |
|
45
Instil Bio
TIL
$213M
| $28M | 0.59% |
+55,787
| New | +$28M |
|
46
Sotera Health
SHC
$4.44B
| $27.7M | 0.58% |
1,111,000
| – | – |
|
47
Amicus Therapeutics
FOLD
$2.46B
| $26.7M | 0.56% |
+2,698,497
| New | +$26.7M |
|
48
BioCryst Pharmaceuticals
BCRX
$1.74B
| $26.5M | 0.56% |
2,605,380
-3,230,430
| -55% | -$32.9M |
|
49
KalVista Pharmaceuticals
KALV
$796M
| $26.2M | 0.55% |
+1,020,005
| New | +$26.2M |
|
|
PROF
50
Profound Medical
PROF
$124M
| $26.1M | 0.55% |
1,297,797
+602,797
| +87% | +$12.1M |
|